EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Human Placental Mesenchymal Stem Cells and Derived Extracellular Vesicles Ameliorate Lung Injury in Acute Respiratory Distress Syndrome Murine Model

Paulius Valiukevičius iD, Justinas Mačiulaitis, Dalia Pangonytė, Vitalija Siratavičiūtė, Katarzyna Kluszczyńska iD, Ugnė Kuzaitytė, Rūta Insodaitė iD, Ieva Čiapienė iD, Ramunė Grigalevičiūtė, Vilma Zigmantaitė, Astra Vitkauskienė, Romaldas Mačiulaitis

Cells · 2023

DOI: 10.3390/cells12232729 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Paulius Valiukevičius und 11 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania. Hauptthemen laut MEDLINE: Lung Injury, Respiratory Distress Syndrome, Extracellular Vesicles, Mesenchymal Stem Cells. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Lietuvos Mokslo Taryba, European Regional Development Fund, Research Council of Lithuania (LMTLT).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study investigates the therapeutic potential of human placental mesenchymal stem cells (P-MSCs) and their extracellular vesicles (EVs) in a murine model of acute respiratory distress syndrome (ARDS), a condition with growing relevance due to its association with severe COVID-19. We induced ARDS-like lung injury in mice using intranasal LPS instillation and evaluated histological changes, neutrophil accumulation via immunohistochemistry, bronchoalveolar lavage fluid cell count, total protein, and cytokine concentration, as well as lung gene expression changes at three time points: 24, 72, and 168 h. We found that both P-MSCs and EV treatments reduced the histological evidence of lung injury, decreased neutrophil infiltration, and improved alveolar barrier integrity. Analyses of cytokines and gene expression revealed that both treatments accelerated inflammation resolution in lung tissue. Biodistribution studies indicated negligible cell engraftment, suggesting that intraperitoneal P-MSC therapy functions mostly through soluble factors. Overall, both P-MSC and EV therapy ameliorated LPS-induced lung injury. Notably, at the tested dose, EV therapy was more effective than P-MSCs in reducing most aspects of lung injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung InjuryRespiratory Distress SyndromeExtracellular VesiclesMesenchymal Stem CellsPregnancyHumansAnimalsFemaleMiceDisease Models, AnimalLipopolysaccharidesTissue DistributionPlacentaCytokines

Stichwörter der Autor:innen

COVID-19acute respiratory distress syndrome (ARDS)exosomesextracellular vesicles (EVs)good manufacturing practice (GMP)immunomodulationinflammationmesenchymal stem cells (MSCs)preclinical model

Substanzen

LipopolysaccharidesCytokines

Autor:innen und Institutionen

  • Faculty of Medicine, Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania.
  • Institute of Physiology and Pharmacology, Faculty of Medicine, Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania.
  • Laboratory of Cardiac Pathology, Institute of Cardiology, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania.
  • Department of Molecular Biology of Cancer, Medical University of Lodz, 90-419 Lodz, Poland.
  • Institute of Cardiology, Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania.
  • Biological Research Center, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania.

ORCID-Profile: Paulius Valiukevičius, Katarzyna Kluszczyńska, Rūta Insodaitė, Ieva Čiapienė

Förderung

  • Lietuvos Mokslo Taryba
  • European Regional Development Fund
  • Research Council of Lithuania (LMTLT)
  • European Union

Zitieren

APA

Valiukevičius, P., Mačiulaitis, J., Pangonytė, D., Siratavičiūtė, V., Kluszczyńska, K., Kuzaitytė, U., Insodaitė, R., Čiapienė, I., Grigalevičiūtė, R., Zigmantaitė, V., Vitkauskienė, A., & Mačiulaitis, R. (2023). Human Placental Mesenchymal Stem Cells and Derived Extracellular Vesicles Ameliorate Lung Injury in Acute Respiratory Distress Syndrome Murine Model. Cells. https://doi.org/10.3390/cells12232729

Vancouver

Valiukevičius P, Mačiulaitis J, Pangonytė D, Siratavičiūtė V, Kluszczyńska K, Kuzaitytė U, et al. Human Placental Mesenchymal Stem Cells and Derived Extracellular Vesicles Ameliorate Lung Injury in Acute Respiratory Distress Syndrome Murine Model. Cells. 2023. doi:10.3390/cells12232729

BibTeX
@article{Valiukeviius2023,
  author = {Valiukevičius, Paulius and Mačiulaitis, Justinas and Pangonytė, Dalia and Siratavičiūtė, Vitalija and Kluszczyńska, Katarzyna and Kuzaitytė, Ugnė and Insodaitė, Rūta and Čiapienė, Ieva and Grigalevičiūtė, Ramunė and Zigmantaitė, Vilma and Vitkauskienė, Astra and Mačiulaitis, Romaldas},
  title = {Human Placental Mesenchymal Stem Cells and Derived Extracellular Vesicles Ameliorate Lung Injury in Acute Respiratory Distress Syndrome Murine Model},
  journal = {Cells},
  year = {2023},
  doi = {10.3390/cells12232729}
}
Kostenlos starten →